Methods to treat opioid use disorder
Abstract:
The disclosure provides sustained-release buprenorphine formulations that produce therapeutic plasma concentration levels of buprenorphine in patients to treat opioid use disorder.
Public/Granted literature
Information query
Patent Agency Ranking
0/0